Coverage Evaluation and Compliance of Mass Drug Administration Campaign in Nanded District of Maharashtra
Keywords:
Mass Drug Administration, MDA, Lymphatic Filariasis, Drug Compliance, Coverage Rate, Coverage Compliance gapAbstract
Background: Lymphatic filariasis (LF) is endemic in 83 countries and territories. In view with the global elimination, mass drug administration (MDA) with single dose of diethyl carbamazine and albendazole tablets was carried out for the eligible population in Nanded district. The study was conducted to assess coverage, compliance and reasons for noncompliance to MDA in Nanded district.
Method: A community-based cross-sectional study was done by house-to-house visit in Nanded district. Three rural and one urban clusters of Nanded district, Maharashtra, were selected. A predesigned questionnaire was used to collect information. Drug coverage, compliance, effective coverage, coverage–compliance gap (CCG), reasons for noncompliance were studied. Statistical analysis was done by SPSS version 16.
Results: The total numbers of houses surveyed were 120. Coverage rate was 94.40%, and compliance rate, CCG, effective coverage rate was 51.81%, 8.48%, and 48.91%, respectively. The compliance of drugs by eligible population was slightly higher in urban area (95.41%) than the rural area (90.56%). Major reasons for non consumption of drug were empty stomach during Drug distributor (DD) visit.
Conclusion: The drug compliance need to be improved. Issues like fear of side effects should be addressed through effective behavior change communication strategies.
References
Krentel A, Fischer P, Manoempil P, Supali T, Servais G, Rückert P. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promo-tion campaign for mass drug administration in Alor District, Indonesia. Trop Med Int Health 2006;11:1731-40
World Health Organization. Life in the 21 st century: A vi-sion for all. The World Health Report 1998. Available from: http://www.who.int/whr/1998/en/whr98 en.pdf. Last ac-cessed on 2017 Apr 15.
World Health Organization. Regional Strategic Plan for Elimination of Lymphatic Filariasis(2004-2007)2004;1-2. Available from: http://www.searo.who.int/LinkFiles/New Lymphatic Filariasis_Regional_Strategic_Plan_LF 2004-2007.pdf. Last accessed on 2017 Apr 20.
Nujum ZT, Remadevi S, Nirmala C, Rajmohanan K, Indu P, Nair SM. Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination. Tropical parasitology. 2012 Jul;2(2):109–15.
Das PK, Pani SP, Krishnamorthy K. Prospects of elimina-tion of Lymphatic Filariasis in India. ICMR Bulletin. May- June 2002;32.
WHO. Progress report 2000–2009 and strategic plan 2010–2020 of the global programme to eliminate lymphatic filari-asis: halfway towards eliminating lymphatic filariasis.: World Health Organization; 2010.
Babu BV, Babu GR. Coverage of, and compliance with, mass drug administration under the programme to elimi-nate lymphatic filariasis in India: a systematic review. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014 Sep;108(9):538–49. pmid:24728444
Dhariwal AC SP, Bhattacharjee J. Elimination of Lymphatic Filariasis in India: An Update. Journal of the Indian Medical Association. December 2015;113(12).
Nandha B, Sadanandane C, Jambulingam P, Das P. Deliv-ery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pon-dicherry, South India: 5 years of experience. Filaria journal. 2007;6:7. pmid:17718908
Alexander ND. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic fila-riasis elimination. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2015 Mar;109(3):173–4.
WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination pro-grammes.: World Health Organisation; 2011.
Directorate NVBDCP. Guidelines on ELimination of Lym-phatic Filariasis in India. Delhi.: Director General of Health Services, Directorate of National Vector Borne Disease Con-trol ProgramMinistry of Health and Family Welfare, Gov-ernment of India.; 2009.
Godale LB, Balaji UV. A Study on Coverage Evaluation, Compliance and Awareness of Mass Drug Administration for Elimination of Lymphatic Filariasis in Osmanabad Dis-trict.Natl J Community Med 2012; 3(3):391-4.
Marathe N, Chalisgaonkar C. Mass drug administration coverage evaluation for elimination of lymphatic filariasis in Chhatarpur district of Madhya Pradesh. Int J Med Sci Public Health 2015;4:927-932
Patel PK. Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts.Indian J Community Med 2012;37:101-6.
Havale NG. Evaluation of coverage and compliance of elim-ination of lymphatic filariasis by mass drug administration campaign in Gulbarga and Yadgiri districts of Karnataka state. Int J Res Med Sci 2015;3(8):2105-8.
Jothula KY, Naidu NK, Malhotra VM, Prasad VG, Kabra PR, Nagaraj K. Evaluation of mass drug administration programme for elimination of lymphatic filariasis in Nalgonda district, Telangana, India. Int J Community Med Public Health 2016;3:2008-12.
Nirgude AS, Naik PR, Kondagunta N, Sidramappav RS, Anant TA, Prasad VG. Evaluation of coverage and compli-ance of mass drug administration programme 2011 for elim-ination of lymphatic filariasis in Nalgonda district of An-dhra Pradesh, India. Natl J Commun Med 2012;3(2):288–93.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
